Structure-based Drug design

Structure-based design methods have proven effective in every aspect of drug design – from lead discovery, development, through guiding clinical trials. These methods may be used to optimise the  binding affinity of the drug candidate, to finely tune  the specificity of protein-ligand interactions, and for predictive in silico toxicology (off-target binding, CYP450 binding and metabolism). In the group,…